Combo of diabetes, depression increases post-MI mortality

Combo of diabetes, depression increases post-MI mortality

(HealthDay) -- Having both diabetes and depression significantly increases the risk of dying in the years following a heart attack, beyond the increased risk from either condition alone, according to a study published in the March issue of Diabetes Care.

Mariska Bot, from Tilburg University in the Netherlands, and colleagues analyzed data from two multicenter cohort studies, including 2,704 patients who were hospitalized for . Diabetes and depression (defined as a score ≥10) were evaluated during hospitalization. Mortality data were available for 2,525 patients, who were followed for an average of 6.2 years.

The researchers found that, during follow-up, 439 patients died. The mortality rate was 14 percent for patients without diabetes and depression, and was 23, 22, and 47 percent for those with diabetes only, depression only, and both diabetes and depression, respectively. After adjusting for other variables, the hazard ratios for all-cause mortality were 1.38 for patients with diabetes only, 1.39 for those with depression only, and 2.90 for patients with both diabetes and depression.

"We observed an increased mortality risk in post-myocardial infarction patients with both diabetes and depression, beyond the association with mortality of diabetes and depression alone," the authors write.

One of the multicenter cohort studies was funded by the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

A link between antidepressants and type 2 diabetes

Mar 25, 2008

While analyzing data from Saskatchewan health databases, Lauren Brown, researcher with the U of A’s School of Public Health, found people with a history of depression had a 30 per cent increased risk of type 2 Diabetes.

Recommended for you

How does DPP-4 inhibition affect liver function?

5 hours ago

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.